BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 3:52:00 PM | Browse: 1098 | Download: 1190
 |
Received |
|
2013-08-09 08:26 |
|
Peer-Review Started |
|
2013-08-10 11:55 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-09-10 14:20 |
|
Revised |
|
2013-09-20 22:37 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-10-17 14:48 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-10-18 08:05 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
2013-12-12 09:43 |
|
Typeset the Manuscript |
|
2013-12-29 20:13 |
|
Publish the Manuscript Online |
|
2014-01-19 14:17 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Juan Du, Yan-Yan Ma, Chao-Hui Yu and You-Ming Li |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Zhejiang Provincial Natural Science Foundation of China |
LQ13H030002 |
| Medical and Health Science Fund of Health Bureau of Zhejiang Province, China |
2013KYB089 |
|
| Corresponding Author |
You-Ming Li, MD, Department of Gastroenterology, The First Affiliated Hospital, Medical School, Zhejiang University, Hangzhou 310003, Zhejiang Province, China. zlym@zju.edu.cn
|
| Key Words |
Pentoxifylline; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Meta-analysis |
| Core Tip |
Recently, more researchers have been attempting to identify new treatments for nonalcoholic fatty liver disease (NAFLD), however, no firm conclusions have been reached. Thus, it is necessary to conduct a meta-analysis to assess the efficacy of pentoxifylline. Our analysis showed that pentoxifylline therapy significantly decreased body weight, alanine aminotransferase, aspartate transaminase, glucose and tumor necrosis factor-α. Pentoxifylline also reduced the NAFLD activity score and improved lobular inflammation in NAFLD patients.
|
| Publish Date |
2014-01-19 14:17 |
| Citation |
Du J, Ma YY, Yu CH, Li YM. Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2014; 20(2): 569-577 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i2/569.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i2.569 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
